As recent studies show the amount of people taking glucagon-like peptide-1 receptor agonists (GLP-1 agonists) for weight loss, and not for managing type 2 diabetes as originally used, researchers have been examining these medications for potential positive and negative side effects
AOD-9604, sometimes called the fat-burning peptide, showed limited promise in animal studies but has failed to demonstrate consistent results in people, leading the FDA to explicitly state it is not an approved treatment (FDA on unapproved drugs)
Moreover, their presence indicates poor manufacturing standards
Of the 20 amino acids essential for protein synthesis, some must be obtained from food
If you want a broader look at the category, explore our Healthy Aging collection
Ethics declarations Competing interests The author declares that they have no known competing financial and/or non-financial interests or personal relationships that could have appeared to influence the work reported in this paper